AbbVie Inc (NYSE:ABBV)

118.75
Delayed Data
As of Feb 23
 +1.19 / +1.01%
Today’s Change
61.45
Today|||52-Week Range
125.86
+22.79%
Year-to-Date

Today’s Trading

Previous close117.56
Today’s open118.41
Day’s range116.89 - 119.31
Volume4,685,731
Average volume (3 months)6,068,075
Market cap$188.6B
Data as of 4:01pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-9.09%
Earnings growth (this year)+33.41%
Earnings growth (next 5 years)+14.46%
Revenue growth (last year)+10.06%
P/E ratio36.0
Price/Sales5.49
Price/Book37.09

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.28+0.70%
CELGCelgene+1.83+1.95%
BMYBristol-Myers Squibb+2.01+3.05%
GSKGlaxoSmithKline+0.27+0.74%
Data as of 4:02pm ET, 02/23/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$1.44
Annual revenue (last year)$28.2B
Annual profit (last year)$5.3B
Net profit margin18.72%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts